tiprankstipranks
D&D Pharmatech Co., Ltd. (KR:347850)
:347850
South Korea Market

D&D Pharmatech Co., Ltd. (347850) Price & Analysis

Followers

347850 Stock Chart & Stats

₩47550.00
-₩1,250.00(-2.56%)
--

347850 FAQ

What was D&D Pharmatech Co., Ltd.’s price range in the past 12 months?
D&D Pharmatech Co., Ltd. lowest stock price was ₩38950.00 and its highest was ₩116600.00 in the past 12 months.
    What is D&D Pharmatech Co., Ltd.’s market cap?
    D&D Pharmatech Co., Ltd.’s market cap is ₩2.24T.
      When is D&D Pharmatech Co., Ltd.’s upcoming earnings report date?
      D&D Pharmatech Co., Ltd.’s upcoming earnings report date is Nov 13, 2026 which is in 62 days.
        How were D&D Pharmatech Co., Ltd.’s earnings last quarter?
        D&D Pharmatech Co., Ltd. released its earnings results on Aug 14, 2026. The company reported -₩187.466 earnings per share for the quarter.
          Is D&D Pharmatech Co., Ltd. overvalued?
          According to Wall Street analysts D&D Pharmatech Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does D&D Pharmatech Co., Ltd. pay dividends?
            D&D Pharmatech Co., Ltd. does not currently pay dividends.
            What is D&D Pharmatech Co., Ltd.’s EPS estimate?
            D&D Pharmatech Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does D&D Pharmatech Co., Ltd. have?
            D&D Pharmatech Co., Ltd. has 45,837,610 shares outstanding.
              What happened to D&D Pharmatech Co., Ltd.’s price movement after its last earnings report?
              D&D Pharmatech Co., Ltd. reported an EPS of -₩187.466 in its last earnings report. Following the earnings report the stock price went down -0.486%.
                Which hedge fund is a major shareholder of D&D Pharmatech Co., Ltd.?
                Currently, no hedge funds are holding shares in KR:347850
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  D&D Pharmatech Co., Ltd. (347850) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  GC Biopharma Corp.
                  Hanmi Science Co., Ltd
                  Celltrion Pharm Inc.
                  Mezzion Pharma Co., Ltd.
                  PharmaResearch Co., Ltd.
                  Popular Stocks